These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17440007)

  • 1. Poor preservation efficacy versus quality and safety of pediatric extemporaneous liquids.
    Ghulam A; Keen K; Tuleu C; Wong IC; Long PF
    Ann Pharmacother; 2007 May; 41(5):857-60. PubMed ID: 17440007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Antimicrobial Preservation of Extemporaneous Diluted Simple Syrup Vehicles for Pediatrics.
    Santoveña-Estévez A; Suárez-González J; Vera M; González-Martín C; Soriano M; Fariña JB
    J Pediatr Pharmacol Ther; 2018; 23(5):405-409. PubMed ID: 30429695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extemporaneous drug formulations.
    Nahata MC; Allen LV
    Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of the Stability of Extemporaneous Pediatric Oral Formulations.
    Belayneh A; Tessema Z
    ScientificWorldJournal; 2021; 2021():8523091. PubMed ID: 34955693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extemporaneous compounding activities and the associated informational needs of pharmacists.
    Crawford SY; Dombrowski SR
    Am J Hosp Pharm; 1991 Jun; 48(6):1205-10. PubMed ID: 1858798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Brion F; Nunn AJ; Rieutord A
    Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
    Nguyen KQ; Hawkins MG; Taylor IT; Wiebe VJ; Tell LA
    Am J Vet Res; 2009 Jul; 70(7):908-14. PubMed ID: 19566477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA.
    Kiseļova O; Mauriņa B; Šidlovska V
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric formulations--getting to the heart of the problem.
    Standing JF; Tuleu C
    Int J Pharm; 2005 Aug; 300(1-2):56-66. PubMed ID: 15979830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.
    Glass BD; Haywood A
    J Pharm Pharm Sci; 2006; 9(3):398-426. PubMed ID: 17207422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation.
    Garg A; Garg S; She RW
    Burns; 2011 Nov; 37(7):1150-3. PubMed ID: 21764219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are multidose over-the-counter artificial tears adequately preserved?
    Charnock C
    Cornea; 2006 May; 25(4):432-7. PubMed ID: 16670481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extemporaneous preparation of methyldopa in two syrup vehicles.
    Newton DW; Rogers AG; Becker CH; Torosian G
    Am J Hosp Pharm; 1975 Aug; 32(8):817-21. PubMed ID: 238389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-level challenge test for the examination of the microbiological susceptibility, during the period of use, of liquid and semi-solid dosage forms in multiple-dose containers (author's transl)].
    Urban S; Hecker W; Schiller I
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 172(6):478-84. PubMed ID: 7257652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extemporaneous dosage preparations for pediatrics.
    Rappaport PL
    Can J Hosp Pharm; 1983; 36(3):66-70, 74. PubMed ID: 10262678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Conroy S
    Acta Paediatr; 2003 Apr; 92(4):408-10. PubMed ID: 12801103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.